IQVIA's Regulatory Affairs approach integrates technology, analytics, and insights built from years of experience to help biopharma companies exceed global compliance goals, reduce costs and get drugs to market faster.
Our offerings span the drug development continuum where our assistance with the creation of a regulatory strategy and development plan helps eliminate surprises, keep development on track, and ensure appropriate quality strategy at each step.
Intelligent systems, robotic process automation and mobile access are changing what’s possible. IQVIA gives you turnkey access to business-transforming technology, including
At IQVIA, we are also combining multiple capabilities into customized expert systems to enhance productivity to help reduce the burden of administrative tasks.
Enhance patient safety and study quality by using data, analytics, and technology to monitor patient, site, and study performance with risk-based and centralized monitoring.
Use AI, machine learning, NLP and new technologies to streamline pharmacovigilance, improve efficiencies, reduce costs, and meet safety demands.
Create transparency in your regulatory documents with a range of medical writing services that deliver quality and timeliness throughout your product development lifecycle.
Harness the power of automation to execute streamlined end-to-end safety solutions while reducing costs.
Automate and standardize your regulatory management, from correspondence and commitments to registration and tracking.
Proactively address global engagement and transparency regulations with technology solutions that streamline and simplify processes, reduce costs, mitigate risks, and leverage data.